Your browser doesn't support javascript.
loading
Multi-Institutional Outcomes of Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy With a Median Biologically Effective Dose of 100 Gy10 for Non-bone Oligometastases.
Kutuk, Tugce; Herrera, Robert; Mustafayev, Teuta Z; Gungor, Gorkem; Ugurluer, Gamze; Atalar, Banu; Kotecha, Rupesh; Hall, Matthew D; Rubens, Muni; Mittauer, Kathryn E; Contreras, Jessika A; McCulloch, James; Kalman, Noah S; Alvarez, Diane; Romaguera, Tino; Gutierrez, Alonso N; Garcia, Jacklyn; Kaiser, Adeel; Mehta, Minesh P; Ozyar, Enis; Chuong, Michael D.
Afiliación
  • Kutuk T; Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, Florida.
  • Herrera R; Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, Florida.
  • Mustafayev TZ; Department of Radiation Oncology, School of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey.
  • Gungor G; Department of Radiation Oncology, School of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey.
  • Ugurluer G; Department of Radiation Oncology, School of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey.
  • Atalar B; Department of Radiation Oncology, School of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey.
  • Kotecha R; Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, Florida.
  • Hall MD; Department of Radiation Oncology, Herbert Wertheim College of Medicine, Florida International University, Miami, Florida.
  • Rubens M; Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, Florida.
  • Mittauer KE; Department of Radiation Oncology, Herbert Wertheim College of Medicine, Florida International University, Miami, Florida.
  • Contreras JA; Department of Clinical Informatics, Miami Cancer Institute, Baptist Health South Florida, Miami, Florida.
  • McCulloch J; Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, Florida.
  • Kalman NS; Department of Radiation Oncology, Herbert Wertheim College of Medicine, Florida International University, Miami, Florida.
  • Alvarez D; Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, Florida.
  • Romaguera T; Department of Radiation Oncology, Herbert Wertheim College of Medicine, Florida International University, Miami, Florida.
  • Gutierrez AN; Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, Florida.
  • Garcia J; Department of Radiation Oncology, Herbert Wertheim College of Medicine, Florida International University, Miami, Florida.
  • Kaiser A; Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, Florida.
  • Mehta MP; Department of Radiation Oncology, Herbert Wertheim College of Medicine, Florida International University, Miami, Florida.
  • Ozyar E; Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, Florida.
  • Chuong MD; Department of Radiation Oncology, Herbert Wertheim College of Medicine, Florida International University, Miami, Florida.
Adv Radiat Oncol ; 7(6): 100978, 2022.
Article en En | MEDLINE | ID: mdl-35647412
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Adv Radiat Oncol Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Adv Radiat Oncol Año: 2022 Tipo del documento: Article